Pleiotrophin-induced endothelial cell migration is regulated by xanthine oxidase-mediated generation of reactive oxygen species

Microvascular Research

Volumn 98, Issue , 2015, Pages 74-81

  Tsirmoula, Sotiria ^a   Lamprou, Margarita ^a   Hatziapostolou, Maria ^a,c   Kieffer, Nelly ^b   Papadimitriou, Evangelia ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell migration; PTN; ROS; RPTP ; Xanthine oxidase; 3

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MUTANT PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PLEIOTROPHIN; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; RECEPTOR; RECEPTOR PROTEIN TYROSINE PHOSPHATASE BETA; RECEPTOR PROTEIN TYROSINE PHOSPHATASE ZETA; RECOMBINANT PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR; XANTHINE OXIDASE; CARRIER PROTEIN; CSK TYROSINE-PROTEIN KINASE; CYTOKINE; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE;

ANIMAL CELL; ARTICLE; CANCER CELL; CELL MIGRATION; CHO CELL LINE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; TIME; ANIMAL; CELL MOTION; CRICETULUS; CYTOLOGY; INFLAMMATION; MALE; METABOLISM; PROSTATE TUMOR; RNA INTERFERENCE; TUMOR CELL LINE; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; CARRIER PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CHO CELLS; CRICETULUS; CYTOKINES; ENDOTHELIAL CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; INTEGRIN ALPHAVBETA3; MALE; PHOSPHATIDYLINOSITOL 3-KINASES; PROSTATIC NEOPLASMS; REACTIVE OXYGEN SPECIES; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 5; RECOMBINANT PROTEINS; RNA INTERFERENCE; SRC-FAMILY KINASES; XANTHINE OXIDASE;

EID: 84924898226     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2015.01.001     Document Type: Article

References (53)

1. Abdulnour R.E., Peng X., Finigan J.H., Han E.J., Hasan E.J., Birukov K.G., Reddy S.P., Watkins J.E., Kayyali U.S., Garcia J.G., Tuder R.M., Hassoun P.M. Mechanical stress activates xanthine oxidoreductase through MAP kinase-dependent pathways. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 291:L345-L353.
2. Antoine M., Tag C.G., Wirz W., Borkham-Kamphorst E., Sawitza I., Gressner A.M., Kiefer P. Upregulation of pleiotrophin expression in rat hepatic stellate cells by PDGF and hypoxia: implications for its role in experimental biliary liver fibrogenesis. Biochem. Biophys. Res. Commun. 2005, 337:1153-1164.
3. Bir S.C., Kolluru G.K., Fang K., Kevil C.G. Redox balance dynamically regulates vascular growth and remodeling. Semin. Cell Dev. Biol. 2012, 23:745-757.
4. Bryan N., Ahswin H., Smart N., Bayon Y., Wohlert S., Hunt J.A. Reactive oxygen species (ROS)-a family of fate deciding molecules pivotal in constructive inflammation and wound healing. Eur. Cell Mater. 2012, 24:249-265.
5. Dhar-Mascareno M., Chen J., Zhang R.H., Carcamo J.M., Golde D.W. Granulocyte-macrophage colony-stimulating factor signals for increased glucose transport via phosphatidylinositol 3-kinase- and hydrogen peroxide-dependent mechanisms. J. Biol. Chem. 2003, 278:11107-11114.
6. Dupont G.P., Huecksteadt T.P., Marshall B.C., Ryan U.S., Michael J.R., Hoidal J.R. Regulation of xanthine dehydrogenase and xanthine oxidase activity and gene expression in cultured rat pulmonary endothelial cells. J. Clin. Invest. 1992, 89:197-202.
7. Goitre L., Pergolizzi B., Ferro E., Trabalzini L., Retta S.F. Molecular crosstalk between integrins and cadherins: do reactive oxygen species set the talk?. J. Signal Transduct. 2012, 2012:807682.
8. Griguer C.E., Oliva C.R., Kelley E.E., Giles G.I., Lancaster J.R., Gillespie G.Y. Xanthine oxidase-dependent regulation of hypoxia-inducible factor in cancer cells. Cancer Res. 2006, 66:2257-2263.
9. Güleç M., Akin H., Yüce H.H., Ergin E., Elyas H., Yalçin O., Akyol O. Adenosine deaminase and xanthine oxidase activities in bladder washing fluid from patients with bladder cancer: a preliminary study. Clin. Biochem. 2003, 36:193-196.
10. Hatziapostolou M., Delbe J., Katsoris P., Polytarchou C., Courty J., Papadimitriou E. Heparin affin regulatory peptide is a key player in prostate cancer cell growth and angiogenicity. Prostate 2005, 65:151-158.
11. Hatziapostolou M., Polytarchou C., Katsoris P., Courty J., Papadimitriou E. Heparin affin regulatory peptide/pleiotrophin mediates fibroblast growth factor 2 stimulatory effects on human prostate cancer cells. J. Biol. Chem. 2006, 281:32217-32226.
12. Heissig B., Ohki-Koizumi M., Tashiro Y., Gritli I., Sato-Kusubata K., Hattori K. New functions of the fibrinolytic system in bone marrow cell-derived angiogenesis. Int. J. Hematol. 2012, 95:131-137.
13. Heumüller S., Wind S., Barbosa-Sicard E., Schmidt H.H., Busse R., Schröder K., Brandes R.P. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 2008, 51:211-217.
14. Holmström K.M., Finkel T. Cellular mechanisms and physiological consequences of redox-dependent signalling. Nat. Rev. Mol. Cell Biol. 2014, 15:411-421.
15. Kalyanaraman B., Darley-Usmar V., Davies K.J., Dennery P.A., Forman H.J., Grisham M.B., Mann G.E., Moore K., Roberts L.J., Ischiropoulos H. Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations. Free Radic. Biol. Med. 2012, 52:1-6.
16. Kim Y.W., Byzova T.V. Oxidative stress in angiogenesis and vascular disease. Blood 2014, 123:625-631.
17. Kojima S., Inui T., Muramatsu H., Kimura T., Sakakibara S., Muramatsu T. Midkine is a heat and acid stable polypeptide capable of enhancing plasminogen activator activity and neurite outgrowth extension. Biochem. Biophys. Res. Commun. 1995, 216:574-581.
18. Komaki Y., Sugiura H., Koarai A., Tomaki M., Ogawa H., Akita T., Hattori T., Ichinose M. Cytokine-mediated xanthine oxidase upregulation in chronic obstructive pulmonary disease's airways. Pulm. Pharmacol. Ther. 2005, 18:297-302.
19. Kou B., Ni J., Vatish M., Singer D.R. Xanthine oxidase interaction with vascular endothelial growth factor in human endothelial cell angiogenesis. Microcirculation 2008, 15:251-267.
20. Koutsioumpa M., Polytarchou C., Courty J., Zhang Y., Kieffer N., Mikelis C., Skandalis S.S., Hellman U., Iliopoulos D., Papadimitriou E. Interplay between αvβ3 integrin and nucleolin regulates human endothelial and glioma cell migration. J. Biol. Chem. 2013, 288:343-354.
21. Lange S., Heger J., Euler G., Wartenberg M., Piper H.M., Sauer H. Platelet-derived growth factor BB stimulates vasculogenesis of embryonic stem cell-derived endothelial cells by calcium-mediated generation of reactive oxygen species. Cardiovasc. Res. 2009, 81:159-168.
22. Li F., Tian F., Wang L., Williamson I.K., Sharifi B.G., Shah P.K. Pleiotrophin (PTN) is expressed in vascularized human atherosclerotic plaques: IFN-{gamma}/JAK/STAT1 signaling is critical for the expression of PTN in macrophages. FASEB J. 2010, 24:810-822.
23. Linder N., Haglund C., Lundin M., Nordling S., Ristimäki A., Kokkola A., Mrena J., Wiksten J.P., Lundin J. Decreased xanthine oxidoreductase is a predictor of poor prognosis in early-stage gastric cancer. J. Clin. Pathol. 2006, 59:965-971.
24. Lisanti M.P., Martinez-Outschoorn U.E., Lin Z., Pavlides S., Whitaker-Menezes D., Pestell R.G., Howell A., Sotgia F. Hydrogen peroxide fuels aging, inflammation, cancer metabolism and metastasis: the seed and soil also needs "fertilizer". Cell Cycle 2011, 10:2440-2449.
25. Lu K.V., Jong K.A., Kim G.Y., Singh J., Dia E.Q., Yoshimoto K., Wang M.Y., Cloughesy T.F., Nelson S.F., Mischel P.S. Differential induction of glioblastoma migration and growth by two forms of pleiotrophin. J. Biol. Chem. 2005, 280:26953-26964.
26. Mikelis C., Sfaelou E., Koutsioumpa M., Kieffer N., Papadimitriou E. Integrin alpha(v)beta(3) is a pleiotrophin receptor required for pleiotrophin-induced endothelial cell migration through receptor protein tyrosine phosphatase beta/zeta. FASEB J. 2009, 23:1459-1469.
27. Naik E., Dixit V.M. Mitochondrial reactive oxygen species drive proinflammatory cytokine production. J. Exp. Med. 2011, 208:417-420.
28. Nomura J., Busso N., Ives A., Matsui C., Tsujimoto S., Shirakura T., Tamura M., Kobayashi T., So A., Yamanaka Y. Xanthine oxidase inhibition by febuxostat attenuates experimental atherosclerosis in mice. Sci. Rep. 2014, 4:4554.
29. Omori H., Kawada N., Inoue K., Ueda Y., Yamamoto R., Matsui I., Kaimori J., Takabatake Y., Moriyama T., Isaka Y., Rakugi H. Use of xanthine oxidase inhibitor febuxostat inhibits renal interstitial inflammation and fibrosis in unilateral ureteral obstructive nephropathy. Clin. Exp. Nephrol. 2012, 16:549-556.
30. Pantazaka E., Papadimitriou E. PTN (pleiotrophin). Atlas Genet. Cytogenet. Oncol. Haematol. 2012, 16:821-837.
31. Papadimitriou E., Mikelis C., Lampropoulou E., Koutsioumpa M., Theochari K., Tsirmoula S., Theodoropoulou C., Lamprou M., Sfaelou E., Vourtsis D., Boudouris P. Roles of pleiotrophin in tumor growth and angiogenesis. Eur. Cytokine Netw. 2009, 20:180-190.
32. Polykratis A., Katsoris P., Courty J., Papadimitriou E. Characterization of heparin affin regulatory peptide signaling in human endothelial cells. J. Biol. Chem. 2005, 280:22454-22461.
33. Polytarchou C., Papadimitriou E. Antioxidants inhibit angiogenesis in vivo through down-regulation of nitric oxide synthase expression and activity. Free Radic. Res. 2004, 38:501-508.
34. Polytarchou C., Papadimitriou E. Antioxidants inhibit human endothelial cell functions through down-regulation of endothelial nitric oxide synthase activity. Eur. J. Pharmacol. 2005, 510:31-38.
35. Polytarchou C., Hatziapostolou M., Papadimitriou E. Hydrogen peroxide stimulates proliferation and migration of human prostate cancer cells through activation of activator protein-1 and up-regulation of the heparin affin regulatory peptide gene. J. Biol. Chem. 2005, 280:40428-40435.
36. Polytarchou C., Hatziapostolou M., Poimenidi E., Mikelis C., Papadopoulou A., Parthymou A., Papadimitriou E. Nitric oxide stimulates migration of human endothelial and prostate cancer cells through up-regulation of pleiotrophin expression and its receptor protein tyrosine phosphatase beta/zeta. Int. J. Cancer 2009, 124:1785-1793.
37. Prajda N., Weber G. Malignant transformation-linked imbalance: decreased xanthine oxidase activity in hepatomas. FEBS Lett. 1975, 59:245-249.
38. Prajda N., Morris H.P., Weber G. Imbalance of purine metabolism in hepatomas of different growth rates as expressed in behavior of xanthine oxidase (EC 1.2.3.2). Cancer Res 1976, 36:4639-4646.
39. Ray P.D., Huang B.W., Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell. Signal. 2012, 24:981-990.
40. Romagnoli M., Gomez-Cabrera M.C., Perrelli M.G., Biasi F., Pallardó F.V., Sastre J., Poli G., Viña J. Xanthine oxidase-induced oxidative stress causes activation of NF-kappaB and inflammation in the liver of type I diabetic rats. Free Radic. Biol. Med. 2010, 49:171-177.
41. Sabán-Ruiz J., Alonso-Pacho A., Fabregate-Fuente M., de la Puerta González-Quevedo C. Xanthine oxidase inhibitor febuxostat as a novel agent postulated to act against vascular inflammation. Antiinflamm. Antiallergy Agents Med. Chem. 2013, 12:94-99.
42. Samra Z.Q., Pervaiz S., Shaheen S., Dar N., Athar M.A. Determination of oxygen derived free radicals producer (xanthine oxidase) and scavenger (paraoxonase1) enzymes and lipid parameters in different cancer patients. Clin. Lab. 2011, 57:741-747.
43. Schröder K., Vecchione C., Jung O., Schreiber J.G., Shiri-Sverdlov R., van Gorp P.J., Busse R., Brandes R.P. Xanthine oxidase inhibitor tungsten prevents the development of atherosclerosis in ApoE knockout mice fed a Western-type diet. Free Radic. Biol. Med. 2006, 41:1353-1360.
44. 2 generation: redox signaling and oxidative stress. J. Biol. Chem. 2014, 289:8735-8741.
45. Silver K., Desormaux A., Freeman L.C., Lillich J.D. Expression of pleiotrophin, an important regulator of cell migration, is inhibited in intestinal epithelial cells by treatment with non-steroidal anti-inflammatory drugs. Growth Factors 2012, 30:258-266.
46. Terman B.I., Dougher-Vermazen M., Carrion M.E., Dimitrov D., Armellino D.C., Gospodarowicz D., Bohlen P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun. 1992, 187:1579-1586.
47. Tsirmoula S., Dimas K., Hatziapostolou M., Lamprou M., Ravazoula P., Papadimitriou E. Implications of pleiotrophin in human PC3 prostate cancer cell growth in vivo. Cancer Sci. 2012, 103:1826-1832.
48. Ushio-Fukai M. VEGF signaling through NADPH oxidase-derived ROS. Antioxid. Redox Signal. 2007, 9:731-739.
49. Wang G., Qian P., Jackson F.R., Qian G., Wu G. Sequential activation of JAKs, STATs and xanthine dehydrogenase/oxidase by hypoxia in lung microvascular endothelial cells. Int. J. Biochem. Cell Biol. 2008, 40:461-470.
50. Wilkinson-Berka J.L., Rana I., Armani R., Agrotis A. Reactive oxygen species, Nox and angiotensin II in angiogenesis: implications for retinopathy. Clin. Sci. (Lond.) 2013, 124:597-615.
51. Wind S., Beuerlein K., Eucker T., Müller H., Scheurer P., Armitage M.E., Ho H., Schmidt H.H., Wingler K. Comparative pharmacology of chemically distinct NADPH oxidase inhibitors. Br. J. Pharmacol. 2010, 161:885-898.
52. Yokoi H., Kasahara M., Mori K., Ogawa Y., Kuwabara T., Imamaki H., Kawanishi T., Koga K., Ishii A., Kato Y., Mori K.P., Toda N., Ohno S., Muramatsu H., Muramatsu T., Sugawara A., Mukoyama M., Nakao K. Pleiotrophin triggers inflammation and increased peritoneal permeability leading to peritoneal fibrosis. Kidney Int. 2012, 81:160-169.
53. Zhang Q., Tao K., Huang W., Tian Y., Liu X. Elevated expression of pleiotrophin in human hypertrophic scars. J. Mol. Histol. 2013, 44:91-96.